EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 8 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 248,674 | $2,481,767 | 0.92% |
| Verition Fund Management LLC | 397,603 | $3,968,078 | 0.06% |
| HGC Investment Management Inc. | 79,150 | $793 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1 | $10 | 0.00% |
| CLEAR STREET LLC | 2,640 | $26 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,635 | $26,297 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 400 | $3,936 | 0.00% |